Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026
WESTLAKE VILLAGE, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report its third quarter 2026 financial results and provide a business update after the U.S. financial markets close on Wednesday, November 4, 2026. The Company will host a conference call and webcast at 4:30 p.m. ET that same day. A live webcast of th
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo